Article
Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances…
medRxiv · 2024 · Gui, F.; Jiang, B.; Jiang, J.; He, Z.; Tsujino, T.; Takai, T.; Arai, S.; Pana, C.; Koellermann, J.; Bradshaw, G. A.; Eisert, R.; Kalocsay, M.; Fassl, A.; Balk, S. P.; Kibel, A. S.; Jia, L.
Key facts
| Title | Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate Cancer |
|---|---|
| First author | Gui, F.; Jiang, B.; Jiang, J.; He, Z.; Tsujino, T.; Takai, T.; Arai, S.; Pana, C.; Koellermann, J.; Bradshaw, G. A.; Eisert, R.; Kalocsay, M.; Fassl, A.; Balk, S. P.; Kibel, A. S.; Jia, L. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.07.09.602803 |
| Devices mentioned | K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186, K854187 and 1 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 2 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1